Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10

13 Jun 2003

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clostridium difficile and Clostridium perfringens research
Share to Escherichia coli research studies
Share to Viral gastroenteritis research and epidemiology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 12808464
DOI: 10.1038/nbt840

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10PMID 12808464Read ↗

Genetically modified Lactococcus lactis: novel tools for drug deliverySemantic proximity Read ↗

<i>Lactococcus lactis</i>as a live vector for mucosal delivery of therapeutic proteinsSemantic proximity Read ↗

Lactococcus lactis as a Cell Factory for Delivery of Therapeutic ProteinsSemantic proximity Read ↗

Therapeutic Drug Delivery by Genetically Modified <i>Lactococcus lactis</i>Semantic proximity Read ↗

Mucosal targeting of therapeutic molecules using genetically modified lactic acid bacteria: an updateSemantic proximity Read ↗

Genetically engineered bacteria as inflammatory bowel disease therapeuticsSemantic proximity Read ↗

Engineering lactococci and lactobacilli for human healthSemantic proximity Read ↗

Use of genetically modified lactic acid bacteria and bifidobacteria as live delivery vectors for human and animal healthSemantic proximity Read ↗

Effects in the use of a genetically engineered strain of<i>Lactococcus lactis</i>delivering in situ IL-10 as a therapy to treat low-grade colon inflammationSemantic proximity Read ↗

Lactococci and lactobacilli as mucosal delivery vectors for therapeutic proteins and DNA vaccinesSemantic proximity Read ↗

Use of Native Lactococci as Vehicles for Delivery of DNA into Mammalian Epithelial CellsSemantic proximity Read ↗

Next generation probiotics: Engineering live biotherapeuticsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.